OMX Copenhagen 20

OMX Copenhagen 20 handeln
1.544,40 PKT +5,93 PKT +0,39 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0AEM7


Analysen zu OMX Copenhagen 20-Werten

Datum Rating Analyst
30.05.18 Novo Nordisk Neutral JP Morgan Chase & Co.
29.05.18 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
14.05.18 Novo Nordisk Hold Jefferies & Company Inc.
08.05.18 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
04.05.18 Novo Nordisk Neutral JP Morgan Chase & Co.
03.05.18 Novo Nordisk Verkaufen DZ BANK
03.05.18 Novo Nordisk buy Deutsche Bank AG
03.05.18 Novo Nordisk buy UBS AG
03.05.18 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
03.05.18 Novo Nordisk Neutral Credit Suisse Group
02.05.18 Novo Nordisk Neutral JP Morgan Chase & Co.
02.05.18 Novo Nordisk buy UBS AG
02.05.18 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
25.04.18 Novo Nordisk buy UBS AG
25.04.18 Novo Nordisk Neutral JP Morgan Chase & Co.
20.04.18 Novo Nordisk Neutral JP Morgan Chase & Co.
18.04.18 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
13.04.18 Novo Nordisk Hold Jefferies & Company Inc.
12.04.18 Novo Nordisk buy Deutsche Bank AG
11.04.18 Novo Nordisk market-perform Bernstein Research
27.03.18 Novo Nordisk buy UBS AG
19.03.18 Novo Nordisk market-perform Bernstein Research
08.03.18 Novo Nordisk Underweight Barclays Capital
05.03.18 Novo Nordisk Neutral JP Morgan Chase & Co.
26.02.18 Novo Nordisk Hold Jefferies & Company Inc.
23.02.18 Novo Nordisk Neutral JP Morgan Chase & Co.
23.02.18 Novo Nordisk buy Deutsche Bank AG
22.02.18 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
21.02.18 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
20.02.18 Novo Nordisk Hold Kepler Cheuvreux
19.02.18 Novo Nordisk buy UBS AG
14.02.18 Novo Nordisk Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.02.18 Novo Nordisk buy UBS AG
06.02.18 Novo Nordisk Hold S&P Capital IQ
02.02.18 Novo Nordisk Neutral JP Morgan Chase & Co.
02.02.18 Novo Nordisk buy Deutsche Bank AG
02.02.18 Novo Nordisk buy UBS AG
02.02.18 Novo Nordisk buy Goldman Sachs Group Inc.
02.02.18 Novo Nordisk buy Goldman Sachs Group Inc.
01.02.18 Novo Nordisk buy UBS AG